1
|
Nguyen T, Chitturi K, Tarun T, Alderson T, Bowers K, Dresser T, Karuparthi P, Aggarwal K, Markley J, Littrell R. NEW APPEARANCE OF AN OLD ENEMY: CARDIAC SARCOIDOSIS PRESENTING AS CONSTRICTIVE PERICARDITIS. J Am Coll Cardiol 2021. [DOI: 10.1016/s0735-1097(21)03975-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
2
|
Pierce J, Lee K, Markley J, Pakyz A, Doll M, Kirk A, Bearman G, Cruz ODL, Stevens M. 252. Relative Use of Carbapenems in Immunocompromised Patients. Open Forum Infect Dis 2018. [PMCID: PMC6253351 DOI: 10.1093/ofid/ofy210.263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
Abstract
Background Gram-negative bacterial infections are associated with high mortality in immunocompromised hosts, and the presence of drug resistance further increases mortality. Antibiotic consumption is a key outcome measure for Antimicrobial Stewardship Programs. Proper utilization of antibiotics can help limit the development of antimicrobial resistance. Resistance in Gram-negative organisms such as Pseudomonas, Enterobacter, and Acinetobacter is a major issue given the paucity of new drugs in the antibiotic pipeline for these organisms. A novel relative carbapenem consumption metric (the Proportion of Carbapenem Consumption, or PoCC) was recently described in US academic medical centers. The PoCC is calculated as follows: PoCC = [(meropenem Days of therapy(DOT)/1,000 patient-days (PDs))/(meropenem DOT/1,000 PDs + cefepime DOT/1,000 PDs + piperacillin–tazobactam DOT/1,000 PDs)]. The regional mean PoCC for the South Atlantic region has previously been approximated at 17%. Methods We examined the PoCC for the Bone Marrow Transplant (BMT) and dedicated Hematology/Oncology (H/O) inpatient wards at an academic medical center from August 2012 to June 2017. Results ![]()
![]()
Conclusion This is the first description of the PoCC metric for dedicated Hematology/Oncology and Bone Marrow Transplant wards. When compared with national and regional mean PoCC scores for academic medical centers, the PoCC for these units was higher. More research is needed to determine the optimal PoCC scores for these types of units. The PoCC can contextualize relative carbapenem use and may be a useful antibiotic consumption metric. However, it does not provide data on absolute consumption. Further studies are needed to determine the best use of the PoCC metric by Antimicrobial Stewardship Programs for Hematology/Oncology and Bone Marrow Transplant wards. Disclosures All authors: No reported disclosures.
Collapse
Affiliation(s)
- Jacob Pierce
- Internal Medicine, VCU Commonwealth Health System, Richmond, Virginia
| | - Kimberly Lee
- Virginia Commonwealth University Health System, Richmond, Virginia
| | - John Markley
- Infectious Diseases, Virginia Commonwealth University Health System, Richmond, Virginia
| | - Amy Pakyz
- Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, Virginia
| | | | - Andrew Kirk
- Virginia Commonwealth University School of Medicine, Richmond, Virginia
| | - Gonzalo Bearman
- Infectious Diseases, Virginia Commonwealth University Health System, Richmond, Virginia
| | - Oveimar De La Cruz
- Infectious Diseases, Virginia Commonwealth University Health System, Richmond, Virginia
| | - Michael Stevens
- Infectious Diseases, Virginia Commonwealth University Health System, Richmond, Virginia
| |
Collapse
|
3
|
Molayi A, Kirk A, Markley J, Bernard S, Taylor P, Sanogo K, Lee K, Pakyz A, Doll M, Bearman G, Stevens MP. Description of a restriction program for gram-positive antimicrobial agents at an academic medical center. Am J Infect Control 2018; 46:232-234. [PMID: 29031435 DOI: 10.1016/j.ajic.2017.08.038] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2017] [Revised: 08/25/2017] [Accepted: 08/26/2017] [Indexed: 12/15/2022]
Abstract
This report examines the effectiveness of antimicrobial restriction at 1 tertiary care health care system by analyzing the consumption of restricted versus nonrestricted gram-positive agents over time for medical versus surgical units. Significant reductions in restricted antibiotic use were detected in 57% of medical units versus none of the surgical units. There were no significant reductions in nonrestricted antibiotic use. We think looking at antibiotic consumption by service line provides opportunities for targeted antibiotic restriction program refinement.
Collapse
|
4
|
Westbrook J, Markley J, Haruki, Velankar S, Burley S. PDBx/mmCIF: the foundation for the wwPDB OneDep system. Acta Crystallogr A Found Adv 2017. [DOI: 10.1107/s2053273317082146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
5
|
Westbrook J, Markley J, Nakamura H, Velankar S, Burley S. wwPDB OneDep validation services. Acta Crystallogr A Found Adv 2017. [DOI: 10.1107/s2053273317082523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
6
|
Young JY, Westbrook J, Feng Z, wwPDB Biocuration Team, wwPDB Onedep Team, Markley J, Nakamura H, Velankar S, Burley SK. OneDep: unified wwPDB system for deposition, biocuration and validation of macromolecular structures in the PDB archive. Acta Crystallogr A Found Adv 2017. [DOI: 10.1107/s0108767317099536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
7
|
Sali A, Berman HM, Schwede T, Trewhella J, Kleywegt G, Burley SK, Markley J, Nakamura H, Adams P, Bonvin AMJJ, Chiu W, Peraro MD, Di Maio F, Ferrin TE, Grünewald K, Gutmanas A, Henderson R, Hummer G, Iwasaki K, Johnson G, Lawson CL, Meiler J, Marti-Renom MA, Montelione GT, Nilges M, Nussinov R, Patwardhan A, Rappsilber J, Read RJ, Saibil H, Schröder GF, Schwieters CD, Seidel CAM, Svergun D, Topf M, Ulrich EL, Velankar S, Westbrook JD. Outcome of the First wwPDB Hybrid/Integrative Methods Task Force Workshop. Structure 2015; 23:1156-67. [PMID: 26095030 PMCID: PMC4933300 DOI: 10.1016/j.str.2015.05.013] [Citation(s) in RCA: 139] [Impact Index Per Article: 15.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2015] [Revised: 05/11/2015] [Accepted: 05/18/2015] [Indexed: 01/20/2023]
Abstract
Structures of biomolecular systems are increasingly computed by integrative modeling that relies on varied types of experimental data and theoretical information. We describe here the proceedings and conclusions from the first wwPDB Hybrid/Integrative Methods Task Force Workshop held at the European Bioinformatics Institute in Hinxton, UK, on October 6 and 7, 2014. At the workshop, experts in various experimental fields of structural biology, experts in integrative modeling and visualization, and experts in data archiving addressed a series of questions central to the future of structural biology. How should integrative models be represented? How should the data and integrative models be validated? What data should be archived? How should the data and models be archived? What information should accompany the publication of integrative models?
Collapse
Affiliation(s)
- Andrej Sali
- Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, California Institute for Quantitative Biosciences, Byers Hall Room 503B, University of California, San Francisco, 1700 4(th) Street, San Francisco, CA 94158-2330, USA.
| | - Helen M Berman
- Research Collaboratory for Structural Bioinformatics Protein Data Bank, Center for Integrative Proteomics Research, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Torsten Schwede
- Swiss Institute of Bioinformatics Biozentrum, University of Basel, Klingelbergstrasse 50-70, 4056 Basel, Switzerland
| | - Jill Trewhella
- School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia
| | - Gerard Kleywegt
- Protein Data Bank in Europe, European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
| | - Stephen K Burley
- Research Collaboratory for Structural Bioinformatics Protein Data Bank, Center for Integrative Proteomics Research, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA; Skaggs School of Pharmacy and Pharmaceutical Sciences and San Diego Supercomputer Center, University of California, San Diego, La Jolla, CA 92093, USA
| | - John Markley
- BioMagResBank, Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706-1544, USA
| | - Haruki Nakamura
- Protein Data Bank Japan, Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Paul Adams
- Physical Biosciences Division, Lawrence Berkeley Laboratory, Berkeley, CA 94720-8235, USA; Department of Bioengineering, UC Berkeley, Berkeley, CA 94720, USA
| | - Alexandre M J J Bonvin
- Bijvoet Center for Biomolecular Research, Faculty of Science - Chemistry, Utrecht University, Padualaan 8, Utrecht, 3584 CH, the Netherlands
| | - Wah Chiu
- National Center for Macromolecular Imaging, Baylor College of Medicine, Houston, TX 77030, USA
| | - Matteo Dal Peraro
- Institute of Bioengineering, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL) and Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland
| | - Frank Di Maio
- Department of Biochemistry, University of Washington, Seattle, WA 98195-7370, USA
| | - Thomas E Ferrin
- Department of Pharmaceutical Chemistry and Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biosciences, University of California, San Francisco, 600 16(th) Street, San Francisco, CA 94158-2517, USA
| | - Kay Grünewald
- Division of Structural Biology, Wellcome Trust Centre of Human Genetics, University of Oxford, OX3 7BN Oxford, UK
| | - Aleksandras Gutmanas
- Protein Data Bank in Europe, European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
| | - Richard Henderson
- MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK
| | - Gerhard Hummer
- Department of Theoretical Biophysics, Max Planck Institute of Biophysics, Max-von-Laue Straße 3, 60438 Frankfurt am Main, Germany
| | - Kenji Iwasaki
- Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan
| | - Graham Johnson
- Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biosciences, University of California, San Francisco, 600 16(th) Street, San Francisco, CA 94158-2330, USA
| | - Catherine L Lawson
- Research Collaboratory for Structural Bioinformatics Protein Data Bank, Center for Integrative Proteomics Research, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Jens Meiler
- Department of Chemistry, Center for Structural Biology, Vanderbilt University, Nashville, TN 37235, USA
| | - Marc A Marti-Renom
- Genome Biology Group, Centre Nacional d'Anàlisi Genòmica (CNAG), Gene Regulation, Stem Cells and Cancer Program, Center for Genomic Regulation (CRG) and Institució Catalana de Recerca i Estudis Avançats (ICREA), 08028 Barcelona, Spain
| | - Gaetano T Montelione
- Center for Advanced Biotechnology and Medicine, Department of Molecular Biology and Biochemistry, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA; Department of Biochemistry, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Michael Nilges
- Département de Biologie Structurale et Chimie, Unité de Bioinformatique Structurale, Institut Pasteur, F-75015 Paris, France; Unité Mixte de Recherche 3258, Centre National de la Recherche Scientifique, F-75015 Paris, France
| | - Ruth Nussinov
- Cancer and Inflammation Program, Leidos Biomedical Research Inc., Frederick National Laboratory, National Cancer Institute, Frederick, MD 21702, USA; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
| | - Ardan Patwardhan
- Protein Data Bank in Europe, European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
| | - Juri Rappsilber
- Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK; Department of Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany
| | - Randy J Read
- Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK
| | - Helen Saibil
- Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck College, Malet Street, London WC1E 7HX, UK
| | - Gunnar F Schröder
- Institute of Complex Systems (ICS-6), Forschungszentrum Jülich, 52425 Jülich, Germany; Physics Department, Heinrich-Heine University Düsseldorf, 40225 Düsseldorf, Germany
| | - Charles D Schwieters
- Division of Computational Bioscience, Center for Information Technology, National Institutes of Health, Bethesda, MD 20892-0520, USA
| | - Claus A M Seidel
- Chair for Molecular Physical Chemistry, Heinrich-Heine-Universität, Universitätsstraße 1, 40225 Düsseldorf, Germany
| | - Dmitri Svergun
- European Molecular Biology Laboratory, Hamburg Unit, Notkestrasse 85, 22607 Hamburg, Germany
| | - Maya Topf
- Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck College, Malet Street, London WC1E 7HX, UK
| | - Eldon L Ulrich
- BioMagResBank, Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706-1544, USA
| | - Sameer Velankar
- Protein Data Bank in Europe, European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
| | - John D Westbrook
- Research Collaboratory for Structural Bioinformatics Protein Data Bank, Center for Integrative Proteomics Research, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
| |
Collapse
|
8
|
Alderson T, Kim J, Markley J. Mapping the binding interactions between a specialized Hsp70 chaperone and its Hsp40 co‐chaperone: a direct role for the Hsp40 HPD motif (567.5). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.567.5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- T. Alderson
- Biochemistry University of Wisconsin‐MadisonMadisonWIUnited States
| | - Jin Kim
- Biochemistry University of Wisconsin‐MadisonMadisonWIUnited States
| | - John Markley
- Biochemistry University of Wisconsin‐MadisonMadisonWIUnited States
| |
Collapse
|
9
|
Janzen M, Nichols WK, Markley J, Vogel T, Faizer R. Use of Angio-Seal after iatrogenic trauma. Mo Med 2012; 109:216-218. [PMID: 22860290 PMCID: PMC6179697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
The clinical and intraoperative findings of an iatrogenic injury to a congenitally present right sided ascending aorta treated by deployment of a percutaneous closure device is reported. This is a first literature report of a biodegradable closure system being utililized to treat a puncture to the ascending arch.
Collapse
Affiliation(s)
- Mark Janzen
- Department of Vascular Surgery, University of Missouri School of Medicine, USA.
| | | | | | | | | |
Collapse
|
10
|
Wessel S, Marceau AH, Hu K, Westler M, Markley J, Keck JL. Molecular Interactions in PriC‐mediated DNA Replication Restart. FASEB J 2012. [DOI: 10.1096/fasebj.26.1_supplement.lb88] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Sarah Wessel
- Biomolecular ChemistryUniversity of WisconsinMadisonWI
| | | | - Kaifeng Hu
- National Magnetic Resonance FacilityMadison
| | | | - John Markley
- National Magnetic Resonance FacilityMadison
- BiochemistryUniversity of WisconsinMadisonWI
| | - James L Keck
- Biomolecular ChemistryUniversity of WisconsinMadisonWI
| |
Collapse
|
11
|
Phadke G, Whaley-Connell A, Dalal P, Markley J, Rich A. Acute Cardiac Tamponade: An Unusual Cause of Acute Renal Failure. Cardiorenal Med 2012; 2:83-86. [PMID: 22619656 DOI: 10.1159/000335671] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/08/2011] [Accepted: 12/08/2011] [Indexed: 01/29/2023] Open
Abstract
We are reporting a case of acute renal failure after cardiac surgery due to acute pericardial effusion. The patient had normal baseline renal function but developed acute oliguric renal failure with a significant increase in serum creatinine postoperatively. Pericardiotomy led to an improvement in blood pressure, immediate diuresis and quick recovery of renal function back to baseline. Pericardial tamponade should be included in the consideration of causes of the cardiorenal syndrome.
Collapse
|
12
|
Condomines M, Plotkin J, Markley J, Gunset G, Sadelain M. Retrovirally expressed 4-1BBL dramatically increases proliferation and in vivo persistence of adoptively transferred CD19-targeted T cells, promoting complete tumor elimination. (131.16). The Journal of Immunology 2010. [DOI: 10.4049/jimmunol.184.supp.131.16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Abstract
Human T cells transduced with a chimeric antigen receptor (CAR) composed of an antibody-derived scFv fragment and the CD3ζ chain can recognize and kill tumor cells on binding to the targeted membrane antigen. The co-transduction of a CAR along with CD80 and 4-1BBL induces auto-costimulation enabling high in vivo T cell expansion and tumor rejection in a prostate tumor model. Here we investigated this concept in T cells harboring either a first generation anti-CD19 CAR (19z1) or a second generation CAR (1928z), which additionally comprises the CD28 cytoplasmic domain. We compared the proliferation and anti-tumor activity of 19z1+, 19z1-4-1BBL+, 19z1-CD80+4-1BBL+, 1928z+ and 1928z-4-1BBL+ transduced T cells in a pro B cell leukemia model (NALM-6). Seven days after IV injection into NALM-6 bearing NOD/SCID/IL2Rγnull mice, 1928z-4-1BBL+ CD8 and CD4 T cells accumulated in the bone marrow and the spleen 100 times more than 19z1+ T cells and 10 times more than 1928z+ T cells, corroborating in vitro proliferative responses to repeated antigen exposure. An increased proportion of central memory CD8 T cells was observed in all groups treated with 4-1BBL-expressing cells. Within 15 days, in vivo bioluminescence imaging showed total tumor regression in the 1928z-4-1BBL+ T cell-treated group and partial regression in the other groups. Thus, constitutive 4-1BBL expression drives high proliferation of anti-tumor CD8 T cells, promoting central memory T cell persistence and tumor eradication.
Collapse
Affiliation(s)
- Maud Condomines
- 1Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, NY
| | - Jason Plotkin
- 1Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, NY
| | - John Markley
- 1Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, NY
| | - Gertrude Gunset
- 1Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, NY
| | - Michel Sadelain
- 1Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, NY
| |
Collapse
|
13
|
Zakrzewski JL, Suh D, Markley J, King C, Smith OM, Goldberg G, Jenq R, Holland AM, Lu S, Sant’Angelo D. Off‐the‐shelf tumor immunotherapy with genetically enhanced allogeneic T cell precursors. FASEB J 2008. [DOI: 10.1096/fasebj.22.1_supplement.1077.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Johannes L Zakrzewski
- Isabelle RiviereMichel SadelainMarcel RM van den Brink. Memorial Sloan Kettering Cancer CenterNew YorkNY
| | - David Suh
- Isabelle RiviereMichel SadelainMarcel RM van den Brink. Memorial Sloan Kettering Cancer CenterNew YorkNY
| | - John Markley
- Isabelle RiviereMichel SadelainMarcel RM van den Brink. Memorial Sloan Kettering Cancer CenterNew YorkNY
| | - Christopher King
- Isabelle RiviereMichel SadelainMarcel RM van den Brink. Memorial Sloan Kettering Cancer CenterNew YorkNY
| | - Odette M Smith
- Isabelle RiviereMichel SadelainMarcel RM van den Brink. Memorial Sloan Kettering Cancer CenterNew YorkNY
| | - Gabrielle Goldberg
- Isabelle RiviereMichel SadelainMarcel RM van den Brink. Memorial Sloan Kettering Cancer CenterNew YorkNY
| | - Robert Jenq
- Isabelle RiviereMichel SadelainMarcel RM van den Brink. Memorial Sloan Kettering Cancer CenterNew YorkNY
| | - Amanda M Holland
- Isabelle RiviereMichel SadelainMarcel RM van den Brink. Memorial Sloan Kettering Cancer CenterNew YorkNY
| | - Sydney Lu
- Isabelle RiviereMichel SadelainMarcel RM van den Brink. Memorial Sloan Kettering Cancer CenterNew YorkNY
| | - Derek Sant’Angelo
- Isabelle RiviereMichel SadelainMarcel RM van den Brink. Memorial Sloan Kettering Cancer CenterNew YorkNY
| |
Collapse
|
14
|
|
15
|
|
16
|
Fogh R, Ionides J, Ulrich E, Boucher W, Vranken W, Linge JP, Habeck M, Rieping W, Bhat TN, Westbrook J, Henrick K, Gilliland G, Berman H, Thornton J, Nilges M, Markley J, Laue E. The CCPN project: an interim report on a data model for the NMR community. Nat Struct Biol 2002; 9:416-8. [PMID: 12032555 DOI: 10.1038/nsb0602-416] [Citation(s) in RCA: 103] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
A recent workshop discusses the progress toward integrating NMR data into a unifying data model.
Collapse
Affiliation(s)
- Rasmus Fogh
- Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge, CB2 1GA, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Markley J, Wells W, Horn M, Starnes V, Woo M. Bronchial anastomosis complications: comparison between pediatric living donor double lobar lung transplant and cadaveric double lung recipients. J Heart Lung Transplant 2002. [DOI: 10.1016/s1053-2498(01)00510-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
18
|
Kaas MJ, Dehn D, Dahl D, Frank K, Markley J, Hebert P. A view of prescriptive practice collaboration: perspectives of psychiatric-mental health clinical nurse specialists and psychiatrists. Arch Psychiatr Nurs 2000; 14:222-34. [PMID: 11061236 DOI: 10.1053/apnu.2000.9813] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
A majority of states require collaborative prescribing agreements between advanced practice nurses and physicians. Unfortunately, there is limited research describing the collaboration that occurs between the clinicians who have such prescribing agreements. This exploratory study identifies the characteristics, activities, and outcomes of collaboration between psychiatric-mental health clinical nurse specialists (CNSs) with prescribing agreements and their collaborating psychiatrists. Surveys were sent to all the 73 prescribing psychiatric-mental health CNSs identified by the Minnesota Board of Nursing in 1998 and their primary collaborating psychiatrists. Forty-nine CNSs and 32 psychiatrists returned the surveys with 31 matched collaborating dyads identified. Overall satisfaction with the collaborative relationship was high, CNSs (chi = 4.34/5) and psychiatrists (chi = 4.46/5). Good communication, trust, shared goals for patient outcomes, shared professional values, and respect for clinical competency were identified as important characteristics for effective collaboration. CNSs identified increased professional growth and job satisfaction as professional benefits, while psychiatrists reported shared workload responsibilities. Fewer than half of the CNSs and psychiatrists perceived professional liability as a professional constraint. Psychiatric-mental health CNSs and psychiatrists agreed that the continuity of patient care and efficient access to mental health care were patient benefits. The statistically significant differences between the CNSs' and psychiatrists' responses were related to the number of years they had been in practice, the number of years the CNS had been a prescriber, and the length of time the CNS and psychiatrist had worked together within a collaborative prescribing agreement.
Collapse
Affiliation(s)
- M J Kaas
- School of Nursing, University of Minnesota, Minneapolis 55455, USA
| | | | | | | | | | | |
Collapse
|
19
|
Walter JS, Wheeler JS, Markley J, Chintam R, Blacker LM, Damaser MS. Home monitoring of bladder pressure and volume in individuals with spinal cord injury and multiple sclerosis. J Spinal Cord Med 1998; 21:7-14. [PMID: 9541881 DOI: 10.1080/10790268.1998.11719504] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Individuals with spinal cord injury and multiple sclerosis are at high risk for developing kidney dysfunction due to high bladder pressures. We have developed a device for frequent monitoring of bladder pressures at home in those patients who use intermittent catheterization to empty their bladders. Of eight subjects enrolled in the study, only five conducted home recording of pressure. Vesical and abdominal pressures measured at home were significantly lower than clinical cystometric pressures. However, subtracted detrusor pressures obtained from home records and cystometric records were not significantly different. The home detrusor pressures were consistent over a large time and volume range. Therefore, the home monitoring method could be used to establish a normal range of bladder pressures at home and to rapidly identify high bladder pressures in advance of upper urinary tract deterioration.
Collapse
Affiliation(s)
- J S Walter
- Rehabilitation Research and Development Service, Edward Hines, Jr. Veterans Affairs Hospital, Hines, IL 60141, USA
| | | | | | | | | | | |
Collapse
|
20
|
Leong SA, An Z, Mei B, McEvoy J, Zhao Q, Markley J. Sequences and proteins required for iron-regulated expression ofsid1ofUstilago maydis. ACTA ACUST UNITED AC 1995. [DOI: 10.1139/b95-237] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The molecular biology of the high affinity, siderophore-mediated iron uptake system of the basidiomycete fungus Ustilago maydis is under investigation. Ustilago maydis produces two cyclic peptide siderophores, ferrichrome and ferrichrome A. Biosynthesis of both siderophores is initiated by ornithine-N5-oxygenase, the product of sid1. sid1 mRNA accumulates only during growth under iron starvation conditions in wild-type cells or constitutively in urbs1 mutants, urbs1 encodes a 100-kDa protein with putative Zn finger domains that share sequence identity with those of the GATA family of transcription factors. The promoter region of sid1 was defined by deletion analysis of a 3.0-kb region 5′ to the translational start of sid1 using the Escherichia coli GUS gene as a reporter. Three regions were defined by this analysis to be critical to expression of sid1. These include (i) a 306-bp region containing two GATA sequences and mapping 2.4 kb from the start of translation; (ii) a 439-bp region immediately 5′ to the start of transcription; and (iii) a region encompassing the first intron of sid1. Deletion of the GATA sequences resulted in deregulated expression of sid1, while elimination of the latter two sequences ablated expression of the gene under all circumstances. Current efforts are focused on determining whether Urbsl interacts directly with the sid1 promoter via the GATA sequences and whether this interaction is dependent upon iron. Key words: GATA, transcription factor, siderophore, ferrichrome, iron, Urbs1.
Collapse
|
21
|
Kornguth S, Bersu E, Anderson M, Markley J. Correlation of increased levels of class I MHC H-2Kk in the placenta of murine trisomy 16 conceptuses with structural abnormalities revealed by magnetic resonance microscopy. Teratology 1992; 45:383-91. [PMID: 1533959 DOI: 10.1002/tera.1420450409] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Murine trisomy 16 (mts16) placentas and fetuses, 17-day gestation age, were examined histologically and by magnetic resonance imaging at 9.4 T and compared with control littermate tissues. Placentas were studied by immunohistochemical methods, at 15-days gestational age, for expression of the major histocompatibility complex (MHC) class I H-2Kk cell surface marker. Immunohistochemical studies revealed a markedly increased expression of the MHC marker H-2Kk on cells in the labyrinth of the placenta of mts16. There were differences between the magnetic resonance (MR) images of the trisomic and normal placentas, which may be correlated with the increased expression of H-2Kk in the mts16 placental labyrinth. The decidual and labyrinthine components of the normal placentas showed similar high signal intensities (SI) while in trisomic placentas a marked high SI was characteristic only of the decidual region on proton spin density images. The MRI also revealed a smaller cerebellum in the ts16 fetuses. The potential effects of the compromised structure of the placental labyrinth and the overexpression of the H-2Kk marker on the mts16 neural and placental dysgenesis are discussed.
Collapse
Affiliation(s)
- S Kornguth
- Department of Anatomy, University of Wisconsin-Madison 53705
| | | | | | | |
Collapse
|
22
|
Castro DJ, Saxton RE, Markley J, Foote CS, Fetterman HR, Castro DJ, Ward PH. Argon laser phototherapy of human malignancies using rhodamine-123 as a new laser dye: the intracellular role of oxygen. Laryngoscope 1990; 100:884-91. [PMID: 2166193 DOI: 10.1288/00005537-199008000-00016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Recent studies demonstrated that the cationic, mitochondrial-specific dye Rhodamine-123 (Rh-123), is an efficient tumor photosensitizer for Argon laser treatment of human cancer cells both in vitro and in tumors grown as xenografts in athymic mice. To demonstrate the photodynamic mechanism of action of this reaction, the intracellular role of oxygen and temperature changes in treated cells have to be defined. In the current study, a large panel of human tumor cell lines of diverse histologic origin were tested for in vitro sensitivity to Rh-123 and the Argon laser (514.5 nm) in oxygen, deuterium oxide (D2O), and nitrogen (N2) environment. Tumor cells in suspension were first sensitized to Rh-123 (1 or 20 micrograms/ml for 1 hour), cooled on ice to 4 degrees C, and then exposed to the Argon laser (delta T = 14 +/- 1 degree C). Cell proliferation measured by [3H]-thymidine uptake 24 hours after sensitization with Rh-123 and laser treatment was significantly decreased in tumor cells kept in oxygen and D2O atmospheres. No decrease in DNA synthesis was seen in Rh-123 and laser treated cells kept in an N2 environment. Control tumor cells treated with Rh-123 or the Argon laser separately did not show any decreased [3H]-thymidine uptake in oxygen, D2O or N2 environment. These results provide evidence of a photodynamic process since Rh-123 sensitization and Argon laser activation occur at nonthermal levels of energy and are oxygen dependent. The high effectiveness of this technique of photodynamic therapy with the Argon laser, and low toxicity of Rh-123 could make its clinical use very attractive for the treatment of superficial malignancies.
Collapse
Affiliation(s)
- D J Castro
- Division of Head and Neck Surgery, UCLA School of Medicine, 90024-1624
| | | | | | | | | | | | | |
Collapse
|
23
|
Kornguth S, Anderson M, Turski P, Sorenson J, Robins HI, Cohen J, Rappe A, Markley J. Glioblastoma multiforme: MR imaging at 1.5 and 9.4 T after injection of polylysine-DTPA-Gd in rats. AJNR Am J Neuroradiol 1990; 11:313-8. [PMID: 2156411 PMCID: PMC8334681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Polylysine-DTPA-Gd, a new MR contrast agent, was injected into the aorta of rats 7 days after C6 glioblastoma was implanted in their brains; MR imaging was performed 3 days later. The imaging was done at two field strengths: (1) 1.5 T with a 3-mm slice thickness and in-plane resolutions of 600 microns and (2) 9.4 T with a 125- or 500-microns slice thickness and in-plane resolutions of 95 microns. In animals injected with polylysine-DTPA-Gd (1 microgram or more per rat), the T1-weighted images and mixed T1, T2 images of the C6 glioblastoma revealed a higher signal intensity at the marginal region between tumor and normal brain than that seen in surrounding normal brain. The central tumor region had a low signal intensity. The concentration of Gd in the C6 glioblastoma, after injection of 1 microgram polylysine-DTPA-Gd per rat, was calculated to be 0.14 mumol/l. The central tumor region also had a low signal intensity in animals that were not injected with the contrast agent, but the margin between tumor and normal brain was resolved poorly, if at all. The polylysine-DTPA-Gd revealed the microvasculature of the C6 glioblastoma in the 125-micron-thick slices obtained at 9.4 T. This is the first study to reveal the utility of the 9.4-T MR imager for examination of glioblastomas in situ and to demonstrate the utility of polylysine-DTPA-Gd as a contrast agent for the definition of the margin between glioblastoma and normal brain tissue.
Collapse
Affiliation(s)
- S Kornguth
- Department of Neurology, University of Wisconsin, Madison 53706
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Lucas ZJ, Markley J, Travis M. Immunologic enhancement of renal allografts in the rat. I. Dissociation of graft survival and antibody response. Fed Proc 1970; 29:2041-7. [PMID: 4921562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|